ARTICLE | Company News
ImmuCell other research news
July 11, 1994 7:00 AM UTC
The Portland, Maine, company received a $507,000 Phase II SBIR grant from the National Institute of Allergy and Infectious Diseases to develop its passive antibody product to treat cryptosporidiosis i...